Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AZD-8630 by AstraZeneca for Asthma: Likelihood of Approval
AZD-8630 is under clinical development by AstraZeneca and currently in Phase I for Asthma. According to GlobalData, Phase I drugs...